Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin vs Micafungin in Presumptive Candidemia
NCT00839540Phase 4Completed
- Sponsor
- Gary E. Stein
- Start
- Dec 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of micafungin in candidemia, sponsored by Gary E. Stein. Primary endpoint: Serum Cidal Activity (Log Inhibition of Growth) at 24 hours. Started Dec 2008; status: completed.
02
Drugs
micafungin
03
Conditions
candidemia
Beyond the preview
Go deeper on NCT00839540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839540.